Patients, care partners, survivors, advocates . . . everyone. It’s Our Time!
Watch a video about the promise of cancer research — and its urgency — from the American Association for Cancer Research (AACR).
Patients, care partners, survivors, advocates . . . everyone. It’s Our Time!
Watch a video about the promise of cancer research — and its urgency — from the American Association for Cancer Research (AACR).
One flexible sigmoidoscopy screening between the ages of 55 and 64 reduced both colorectal cancer diagnoses and deaths during a randomized clinical trial in the United Kingdom.
After following 170,000 people for more than 11 years, deaths from colorectal cancer were 43 percent lower among those who had a flexible sigmoidoscopy screening. Diagnosis of colorectal cancer was reduced by 33 percent.
This is the first prospective clinical trial that actually proved that examining the rectum and colon with a scope could reduce colorectal cancer deaths. Read the rest of this entry »
Today, the New York Times published a special profiling 522 cancer survivors in order to highlight some of the challenges they faced after completing treatment. The interviews share insights about life after cancer from survivors across the country. C3 Advocate Paulette Stallone is one of the survivors featured in the article.
As a member of the One Voice Against Cancer (OVAC) we are pleased to be participating in the annual OVAC Lobby Day. Join us in June as we head to the hill to ask Congress to increase funding for cancer research.
Important Dates:
Location: The Liaison Capitol Hill Hotel (415 New Jersey Avenue NW, Washington, DC 20001)
Follow CRCAdvocacy on Twitter for updates on the latest policy news. Not only will we be posting the latest news, but we will also be posting tips on how you can help us in the fight against colorectal cancer. Follow us today at http://twitter.com/CRCAdvocacy, and tell your friends to follow us too! If you’re interested in the latest updates from all of C3, then follow our main Twitter feed which is still @FightCRC.